Quoin Pharmaceuticals, Ltd. (QNRX) › Shareholders' EquityQuoin Pharmaceuticals, Ltd. (QNRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$2.95M2019: -$4.51M2020: -$6.61M2021: $657.0K2022: $7.41M2023: $5.66M2024: $9.20M2025: $13.12M$13.12M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$13.12M+42.5%2024$9.20M+62.5%2023$5.66M-23.5%2022$7.41M+1027.3%2021$657.0K+109.9%2020-$6.61M-46.4%2019-$4.51M-52.9%2018-$2.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share